Filtered by:
18 Programs
-
Second Opinion
Clinical Investigators Provide Perspectives on the Future Role of AKT Inhibition in the Management of Prostate Cancer
-
-
D
-
E
-
P
-
D
-
-
Second Opinion
Integrating Novel Approaches into the Management of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
-
-
A
-
M
-
S
- +1
-
A
-
-
Cancer Conference Update
ESMO Congress 2025 Review — Prostate Cancer
-
-
R
-
R
-
-
R
-
R
-
-
Cancer Conference UpdateESMO Congress 2025 — Urothelial Bladder Cancer and Prostate Cancer
-
-
R
-
T
-
R
-